VUH adopts enhanced recovery for sarcoma surgery
Oct. 13, 2022—Vanderbilt's latest enhanced recovery after surgery clinical pathway was launched last month for adult patients receiving surgery to remove extremity soft tissue sarcomas, which are cancerous tumors that can arise in muscles, tendons, fat, blood vessels and other connective tissue.
Cancer registries and sarcoma research
Sep. 13, 2022—The number of sarcoma research studies that use the two largest U.S. cancer registries is increasing, but over one-third of studies that asked the same research question reported conflicting findings.
Yale surgery chair to discuss cancer’s ‘on’ switch at next Discovery Lecture
Feb. 16, 2022—Renowned surgical oncologist and clinician scientist Nita Ahuja, MD, MBA, chair of the Department of Surgery at Yale School of Medicine, will deliver the next web-based Discovery Lecture.
Cellular antiviral defenses
Jul. 23, 2020—A cellular RNA quality control mechanism was known to restrict replication of RNA viruses. Vanderbilt researchers have discovered it is also antiviral against DNA viruses.
Hot chemotherapy surgery helps save patient’s leg
Mar. 28, 2019—Tom Deweese can keep up with his grandchildren because of a highly specialized surgery using hot chemotherapy that saved his leg.
Boosting sarcoma cell death
Oct. 4, 2017—A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas.
Children’s Hospital patient, doctor bond through music
Aug. 3, 2017—When 17-year-old Ray Cruz was invited to perform at the Ryman Auditorium, he agreed to do it under one condition — that his doctor perform alongside him.
Review highlights financial impact of sarcoma misdiagnosis
Dec. 10, 2015—Malpractice awards and settlements are eight times greater when physicians misdiagnosis sarcoma than when they make other mistakes, according to a review of 32 years of court cases.
Aggressive bone cancers build more blood vessels
Sep. 3, 2014—A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options.
Photo: Sarcoma research support
Apr. 10, 2014—The FTL Sarcoma Fund, in partnership with the T.J. Martell Foundation, recently presented a gift to the Vanderbilt-Ingram Cancer Center in support of sarcoma research in memory of Warner Music Nashville colleague Lindsay Walleman.
Therapeutic target for synovial sarcoma
Nov. 21, 2013—Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer.